J Korean Med Sci.  2024 Jul;39(28):e207. 10.3346/jkms.2024.39.e207.

Incidence of Tuberculosis Among Immigrants in Korea Who Participated in a Latent Tuberculosis Infection Screening Program

• Lee YJ
• Min J
• Myong JP
• Lee YH
• Park YJ
• Kim Y
• Kim G
• Park G
• Lee SS
• Park JS
• Kim JS
• Kim HW

• KMID: 2558245
• DOI: http://doi.org/10.3346/jkms.2024.39.e207

Abstract

Background
With a rapid decrease in tuberculosis (TB) incidence, the significance of latent tuberculosis infection (LTBI) has been underscored in South Korea. Although South Korea does not have a high proportion of immigrants compared to other countries, there is a growing argument that it should actively embrace immigrants as a solution to address issues of low birth rates and population aging. This study aimed to assess TB incidence among immigrants who participated a pilot LTBI screening program in South Korea.
Methods
Records of immigrants participated in a pilot LTBI screening program in South Korea between 2018 and 2019 were linked with Korean National TB Surveillance System to determine TB development. Participants underwent interferon-gamma release assay (IGRA) and chest X-rays. Standardized incidence ratios (SIRs) stratified by age, country of origin’s TB burden was calculated with a reference group of general South Korean population.
Results
Of a total of 9,517 participants, 14 TB cases were identified. Participants with positive IGRA results who did not initiate LTBI treatment showed TB incidence of 312.5 per 100,000 person-years, whereas those with negative results showed TB incidence of 34.4 per 100,000 person-years, resulting in an incidence rate ratio of 9.08 (95% confidence interval [CI], 2.50–32.99). SIR of TB among total participants including those with negative IGRA results was 2.60 (95% CI, 1.54–4.38; P < 0.001), whereas SIR among those with positive IGRA results was 5.86 (95% CI, 3.15–10.89; P < 0.001). In the calculation of SIR among participants with positive IGRA results, those aged under 35 from high TB-burden countries or intermediate TBburden countries showed a high SIR (18.08; 95% CI, 2.55–128.37; P = 0.004), and 11.30 (95% CI, 2.82–45.16; P < 0.001), respectively). Contrary to previous reports that suggest the majority of elderly population with a positive IGRA result were due to remote infection and had a lower TB risk compared to younger ages, SIR among those aged 65 or over from intermediate TB-burden countries was 6.15 (95% CI, 0.87–43.69; P = 0.069), which was comparable to that in younger participants aged between 35 and 49 (SIR, 4.87; 95% CI, 1.22–19.49; P = 0.025) or those aged between 50 and 64 (SIR, 4.62; 95% CI, 1.73–12.31; P = 0.002).
Conclusion
Young immigrants with positive IGRA results from countries with high or intermediate TB burden showed a relatively high TB risk compared to a general South Korea population. In addition, unexpected high TB risk was observed among elderly immigrants with positive IGRA results. In establishing future policies for LTBI in immigrants in South Korea, screenings should primarily focus on younger age group (who aged under 35). Additionally, further research is needed on the high TB risk observed in elderly immigrants.

Keyword

Latent Tuberculosis Infection; Pulmonary Tuberculosis; Immigrants; Interferon-Gamma Release Assay (IGRA); Korea

Figure

• 

  Fig. 1 Flow chart showing the enrollment of participants.LTBI = latent tuberculosis infection, TB = tuberculosis, IGRA = interferon-gamma release assay.

Reference

1. World Health Organization. Global tuberculosis report 2023. Updated 2023. Accessed May 25, 2024. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022 .

2. Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016; 13(10):e1002152. PMID: 27780211.

3. Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health. 2013; 34(1):271–286. PMID: 23244049.

4. World Health Organization. Guidelines on the management of latent tuberculosis infection. Updated 2015. Accessed October 1, 2022. https://www.who.int/publications/i/item/9789241548908 .

5. Korea Disease Control and Prevention Agency. Annual Report on the Notified Tuberculosis in Korea. Cheongju, Korea: Korea Disease Control and Prevention Agency;2022.

6. Go U, Park M, Kim UN, Lee S, Han S, Lee J, et al. Tuberculosis prevention and care in Korea: evolution of policy and practice. J Clin Tuberc Other Mycobact Dis. 2018; 11:28–36. PMID: 31720389.

7. Joint Committee for the Revision of Korean Guidelines for Tuberculosis. Korean Guidelines for Tuberculosis. 4th ed. Cheongju, Korea: Korea Disease Control and Prevention Agency;2020.

8. Kim HW, Kim JS. One step toward a low tuberculosis-burden country: screening for tuberculosis infection among the immigrants and refugees. Tuberc Respir Dis (Seoul). 2020; 83(1):104–105. PMID: 31905438.

9. Yu S, Jeong D, Choi H. The burden and predictors of latent tuberculosis infection among immigrants in South Korea: a retrospective cross-sectional study. BMC Infect Dis. 2021; 21(1):1206. PMID: 34861855.

10. OECD. International migration outlook 2023. Updated 2023. Accessed January 1, 2024. DOI: 10.1787/b0f40584-en.

11. Chung EA. How South Korean Demographics Are Affecting Immigration and Social Change. Washington, D.C., USA: Carnegie Endowment for International Peace;2021.

12. Pareek M, Abubakar I, White PJ, Garnett GP, Lalvani A. Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Eur Respir J. 2011; 37(5):1175–1182. PMID: 21071474.

13. Pareek M, Greenaway C, Noori T, Munoz J, Zenner D. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med. 2016; 14(1):48. PMID: 27004556.

14. Cho H, Seok J, Park Y, Kim HJ, Lee EH, Park J, et al. Cost-effectiveness of age-expanding strategy of latent tuberculosis infection treatment in household contacts in South Korea. Yonsei Med J. 2023; 64(6):366–374. PMID: 37226563.

15. Joint Committee for the Revision of Korean Guidelines for Tuberculosis. Korean Guidelines for Tuberculosis. 3rd ed. Cheongju, Korea: Korea Disease Control and Prevention Agency;2017.

16. Peter W, Mark J. Appendix I: Imperial College – LTBI treatment report: What is the cost-effectiveness of latent tuberculosis infection (LTBI) treatment with different regimens? Updated 2015. Accessed August 30, 2023. https://www.nice.org.uk/guidance/ng33/evidence/appendix-i-imperial-college-ltbi-treatment-report-30-april-2015-80851860834 .

17. National Institute for Health and Care Excellence. Tuberculosis, NICE guideline. Updated 2024. Accessed January 25, 2023. https://www.nice.org.uk/guidance/ng33 .

18. Office for Health Improvement and Disparities. Tuberculosis (TB): migrant health guide. Updated 2023. Accessed January 10, 2024. https://www.gov.uk/guidance/tuberculosis-tb-migrant-health-guide .

19. Ministry of Justice. Republic of Korea. Korea visa portal. Updated 2024. Accessed February 1, 2024. https://www.visa.go.kr/ .

20. Korean Immigration Service, Ministry of Justice. Immigration and Foreigner Policy Statistics Monthly Report. Gwacheon, Korea: Ministry of Justice;2023.

21. Kim BE, Park JW. Is Korea Ready to Accept Migrants? Towards an Inclusive Society. Seoul, Korea: Korean Times;2023.

22. National Assembly Budget Office. Medium and Longer Term Fiscal Issue Analysis: Population Crisis Responses (4): Strategies for Expanding Economically Active Population Through Immigration Policy. Seoul, Korea: National Assembly Budget Office;2023.

23. Statistics Korea. Population Prospects of Koreans and Foreigners Based on the 2021 Population Projections: 2020–2040. Daejeon, Korea: Statistics Korea;2022.

24. Yu S, Jeong D, Kang HY, Kang YA, Lee GI, Choi H. A quasi-experimental study on the effect of pre-entry tuberculosis screening for immigrants on treatment outcomes in South Korea: a difference-in-differences analysis. J Epidemiol Glob Health. 2024; 14(1):154–161. PMID: 38261173.

25. Tuberculosis Collaborators GB. GBD Tuberculosis Collaborators. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect Dis. 2018; 18(12):1329–1349. PMID: 30507459.

26. Dobler CC, Fox GJ, Douglas P, Viney KA, Ahmad Khan F, Temesgen Z, et al. Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives. Eur Respir J. 2018; 52(1):1800591. PMID: 29794133.

27. Cho KS. Tuberculosis control in the Republic of Korea. Epidemiol Health. 2018; 40:e2018036. PMID: 30081621.

28. Kim HW, Min J, Choi JY, Shin AY, Myong JP, Lee Y, et al. Prevalence of latent tuberculosis infection among participants of the national LTBI screening program in South Korea: a problem of low coverage rate with current LTBI strategy. Front Public Health. 2023; 10:1066269. PMID: 36743163.

29. Pareek M, Baussano I, Abubakar I, Dye C, Lalvani A. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis. 2012; 18(9):1422–1429. PMID: 22931959.

30. Centers for Disease Control and Prevention. Tuberculosis technical instructions for panel physicians. Updated 2024. Accessed January 25, 2024. https://www.cdc.gov/immigrant-refugee-health/hcp/panel-physicians/tuberculosis.html .

31. European Centre for Disease Prevention and Control. Programmatic management of latent tuberculosis infection in the European Union. Updated 2018. Accessed January 25, 2023. https://www.ecdc.europa.eu/en/publications-data/programmatic-management-latent-tuberculosis-infection-european-union .

32. D’Ambrosio L, Centis R, Dara M, Solovic I, Sulis G, Zumla A, et al. European policies in the management of tuberculosis among migrants. Int J Infect Dis. 2017; 56:85–89. PMID: 27836793.

33. Campbell JR, Winters N, Menzies D. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis. BMJ. 2020; 368:m549. PMID: 32156698.

34. Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, White PJ, et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis. 2011; 11(6):435–444. PMID: 21514236.

35. Hamada Y, Gupta RK, Quartagno M, Izzard A, Acuna-Villaorduna C, Altet N, et al. Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis. EClinicalMedicine. 2023; 56:101815. PMID: 36636295.

36. Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, et al. Time since infection and risks of future disease for individuals with Mycobacterium tuberculosis infection in the United States. Epidemiology. 2021; 32(1):70–78. PMID: 33009253.

37. Fang Y. A Study of Labor Force Community of Migrant Korean-Chinese in Korea Focusing on Caregivers. Seoul, Korea: Seoul National University;2022.

38. Kim Y. A Study on Foreign Care Workers in South Korea. Sejong, Korea: Korea Institute for Health and Social Affairs;2021.

39. Kim HW, Myong JP, Kim JS. Estimating the burden of nosocomial exposure to tuberculosis in South Korea, a nationwide population based cross-sectional study. Korean J Intern Med. 2021; 36(5):1134–1145. PMID: 33327686.